Citation Impact
Citing Papers
Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival
2008
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Id Proteins
2014
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
2002
Receptor-Binding, Biodistribution, and Metabolism Studies of 64 Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors
2008
Design, Synthesis, and Evaluation of Radiolabeled Integrin α v β 3 Receptor Antagonists for Tumor Imaging and Radiotherapy
2003
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
The redox-senescence axis and its therapeutic targeting
2021
The type 2 human somatostatin receptor as a platform for reporter gene imaging
2002
Shedding light onto live molecular targets
2003 Standout
Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo
2005
Molecular imaging in drug development
2008 Standout
A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
2004
Oxidative stress in prostate cancer
2009
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities
2003
Regional Radiochemotherapy Using In Situ Hydrogel
2005
Selective targeting of cancer cells using synthetic peptides
2003
Molecular imaging with copper-64
2004
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)
2009
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Nuclear Uptake and Dosimetry of 64Cu-Labeled Chelator Somatostatin Conjugates in an SSTr2-Transfected Human Tumor Cell Line
2007
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Taking advantage of luminescent lanthanide ions
2005 Standout
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Novel chelating agents for potential clinical applications of copper
2002
Marine natural products
1990 Standout
Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands
2001
Phaeochromocytoma
2005 Standout
Production and Applications of Copper-64 Radiopharmaceuticals
2004
Integrin αβ3-Targeted Imaging of Lung Cancer
2005
Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
2015
Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging
2012 Standout
Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model
2002
αvβ3 Integrin‐targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
2006
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states
2008
Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS
2005
Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study
2002
MicroPET imaging of breast cancer ?-integrin expression with Cu-labeled dimeric RGD peptides
2004
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
αvβ3-integrin imaging: a new approach to characterise angiogenesis?
2006
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
A novel antiangiogenesis therapy using an integrin antagonist or anti–Flk-1 antibody coated 90Y-labeled nanoparticles
2004
Radiolabeled high affinity peptidomimetic antagonist selectively targets αvβ3 receptor-positive tumor in mice
2007
Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals
2002
Lanthanide Chelates Containing Pyridine Units with Potential Application as Contrast Agents in Magnetic Resonance Imaging
2004
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
One-step 18F labeling of biomolecules using organotrifluoroborates
2015
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
2003
p21 in cancer: intricate networks and multiple activities
2009 Standout
Comparative Dosimetry of Copper-64 and Yttrium-90-Labeled Somatostatin Analogs in a Tumor-Bearing Rat Model
2000
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
High Thermodynamic Stability and Extraordinary Kinetic Inertness of Copper(II ) Complexes with 1,4,8,11‐Tetraazacyclotetradecane‐1,8‐bis(methylphosphonic acid): Example of a Rare Isomerism between Kinetically Inert Penta‐ and Hexacoordinated Copper(II ) Complexes
2002
Bridging the Gap: Modulatory Roles of the Grb2-Family Adaptor, Gads, in Cellular and Allergic Immune Responses
2019
MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide
2004
Copper(ii) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysis
2007
The role of coordination chemistry in the development of target-specific radiopharmaceuticals
2004
Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer
2007
Synthesis and characterization of the copper(ii ) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the64Cu complexes
2008
αvβ3 Integrin‐targeting radionuclide therapy and imaging with monomeric RGD peptide
2008
Radiometallated peptides for molecular imaging and targeted therapy
2011
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
2011
Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals
2006
Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors
2007
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Addressing sleep disturbances: An opportunity to prevent cardiometabolic disease?
2014
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Microenvironmental regulation of metastasis
2008 Standout
Neuroblastoma
2007 Standout
Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: A concise update
2003
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer
2007
Sleep, Health, and Society
2016
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors
2008
Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis
2012
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation
2004
Sleep disparity, race/ethnicity, and socioeconomic position
2015
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
2010
Sleep and cardiovascular disease: Emerging opportunities for psychology.
2018
Design, synthesis and evaluation of near-infrared fluorescent pH indicators in a physiologically relevant range
2005
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Targeted Imaging and Proteomic Analysis of Tumor‐Associated Glycans in Living Animals
2014
Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64
2006
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
2008
Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency
1997
Bombesin marine toxin conjugates inhibit the growth of lung cancer cells
2008
Trends in peptide drug discovery
2021
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
Comparison of Yttrium and Indium Complexes of DOTA-BA and DOTA-MBA: Models for 90Y- and 111In-Labeled DOTA−Biomolecule Conjugates
2002
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
2008
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
2000
Synthesis, Characterization, and X-ray Crystal Structure of In(DOTA-AA) (AA = p-Aminoanilide): A Model for 111In-Labeled DOTA-Biomolecule Conjugates
2003
Molecular Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors in Mice Using64Cu- and86Y-DOTA−(Pro1,Tyr4)-Bombesin(1−14)
2007
microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
2005
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
1999
Radiolabeling and In Vivo Behavior of Copper-64-Labeled Cross-Bridged Cyclam Ligands
2001
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes
2004
A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
2004
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.
2003
Positron Emission Tomography As an Imaging Biomarker
2006
NODAGATOC, a New Chelator-Coupled Somatostatin Analogue Labeled with [67/68Ga] and [111In] for SPECT, PET, and Targeted Therapeutic Applications of Somatostatin Receptor (hsst2) Expressing Tumors
2002
Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency
2000
Structural modification strategies for the rational design of red/NIR region BODIPYs
2014 Standout
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
2005
Synthesis, Characterization and In Vivo Studies of Cu(II)-64-Labeled Cross-Bridged Tetraazamacrocycle-amide Complexes as Models of Peptide Conjugate Imaging Agents
2007
Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
2006
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
2002
Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.
2008
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
2001
Agonist−Antagonist Dilemma in Molecular Imaging: Evaluation of a Monomolecular Multimodal Imaging Agent for the Somatostatin Receptor
2007
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
2005
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
2005
Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.
2005
Hexadentate Bispidine Derivatives as Versatile Bifunctional Chelate Agents for Copper(II) Radioisotopes
2009
Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
2004
Synthesis and Characterization of Two 111In-Labeled DTPA−Peptide Conjugates
2001
Characterization of Somatostatin Receptor Subtype 2 Expression in Stably Transfected A-427 Human Cancer Cells
2007
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Synthesis, Characterization, and Structures of Indium In(DTPA-BA2) and Yttrium Y(DTPA-BA2)(CH3OH) Complexes (BA = Benzylamine): Models for 111In- and 90Y-Labeled DTPA-Biomolecule Conjugates
2004
Ondine's Curse and Neurocristopathy
1980
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
90Y and 111In Complexes of a DOTA-Conjugated Integrin αvβ3 Receptor Antagonist: Different but Biologically Equivalent
2004
Characterization of Novel Histidine-Tagged Tat-Peptide Complexes Dual-Labeled with 99mTc-Tricarbonyl and Fluorescein for Scintigraphy and Fluorescence Microscopy
2002
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Use of Antibody as Carrier of Oligomers of Peptidomimetic αvβ3 Antagonist to Target Tumor-Induced Neovasculature
2007
Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues
2009
Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A Chelates for Targeted Positron Emission Tomography with an αvβ6-Specific Peptide
2009
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability
2012
Synthesis of Target-Specific Radiolabeled Peptides for Diagnostic Imaging
2002
Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography
2012
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Radiometals for Combined Imaging and Therapy
2012
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide.
2007
Imaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH
2005
Creatine and Creatinine Metabolism
2000 Standout
Chemical Glycoproteomics
2016 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver
2000
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
DOTA−d -Tyr1-Octreotate: A Somatostatin Analogue for Labeling with Metal and Halogen Radionuclides for Cancer Imaging and Therapy
2002
Works of Michelle Schmidt being referenced
Radiolabeled RGD-DTPA-Tyr 3 -Octreotate for Receptor-Targeted Radionuclide Therapy
2004
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
2000
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
2001
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer
2003
Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells
2006
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy
1998
[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
2001
Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆
2001
Conditional deletion of SLP‐76 in mature T cells abrogates peripheral immune responses
2011
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
1999
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo
1998
TNFα G308A polymorphism is associated with resilience to sleep deprivation-induced psychomotor vigilance performance impairment in healthy young adults
2014
Evidence for Neuroinflammatory and Microglial Changes in the Cerebral Response to Sleep Loss
2011
[177Lu‐DOTA0,Tyr3]octreotate for somatostatin receptor‐targeted radionuclide therapy
2001
A New Method for the Synthesis of Tri-tert-butyl Diethylenetriaminepentaacetic Acid and Its Derivatives
2000
Guanidinbernsteins�ure und Ur�mie
1971
Safety and Efficacy of the BCL Inhibitors Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
2018
Comparison of Four 64Cu-Labeled Somatostatin Analogues in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy
1999
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
1999
Androgens Regulate the Immune/Inflammatory Response and Cell Survival Pathways in Rat Ventral Prostate Epithelial Cells
2005
Evaluation of a radiolabelled cyclic DTPA‐RGD analogue for tumour imaging and radionuclide therapy
2000
Neurogenic tumors and VIP-induced diarrhea
1979
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
2007
Copper‐64/61 and iodine‐125‐labeled dota‐DTYR1‐octreotate: A new somatostatin analog for labeling with metals and halogens
2001
Identification of the Solublein VivoMetabolites of Indium-111-Diethylenetriaminepentaacetic Acid-d -Phe1-Octreotide
1998
Novel Bioactive and Stable Neurotensin Peptide Analogues Capable of Delivering Radiopharmaceuticals and Molecular Beacons to Tumors
2003